Clinical trial
ABAT - Assessment of Perceived Stress in an Observational Study Evaluating a Biopsy-sparing Surveillance Strategy in Kidney Transplant Recipients With Blood and Urinary Biomarkers Predictive of the Absence of Rejection
NCT07917884 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- ABAT - Assessment of Perceived Stress in an Observational Study Evaluating a Biopsy-sparing Surveillance Strategy in Kidney Transplant Recipients With Blood and Urinary Biomarkers Predictive of the Absence of Rejection
- Lead sponsor
- Nantes University Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- February 1, 2027
- Completion date
- February 1, 2029
- Enrollment
- 66 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal transplant, renal transplantation; complication
Arms
As registered; 1 arm.
-
ABAT Study population
The study population will consist of a prospective cohort of kidney transplant followed at Nantes University Hospital over a 12-month inclusion period.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Perceived stress score related to the 1-year surveillance biopsy
score ranging from 0 to 10, with higher scores indicating high stress level.
Lead sponsor's other trials
Nantes University Hospital, most recent start first.
+833 more trials See the organization page